Mohan Pankaj

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$243,242.80
Insider Sells Quantity
4
Insider Sells Sum
$506,785.02

Insider Activity of Mohan Pankaj

According to the SEC Form 4 filings, Mohan Pankaj, being in a position of

  1. Chairman, President and CEO at Sonnet BioTherapeutics Holdings, Inc.,
    оver the last 12 months, has bought 34375 shares for $55,000, and sold 0 shares,
    over all time since 2020-06-10, has bought 500375 shares for $232,363, and sold 0 shares.

The largest purchase of all time was on 2023-05-15 and amounted to 371600 shares of Sonnet BioTherapeutics Holdings, Inc. for $82,867.

The largest sale of all time was on 2017-12-19 and amounted to 167216 shares of Outlook Therapeutics, Inc. for $190,626.

Biography of Mohan Pankaj

No biography is available at this moment.

2023-10-27PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
Chairman, President and CEO
34,375
2.7322%
$1.60$55,000+27.83%
2023-05-15PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
Chairman, President and CEO
371,600
2.2431%
$0.22$82,867-59.81%
2023-03-15PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
Chairman, President and CEO
60,000
0.3794%
$0.58$35,100-70.6%
2021-06-09PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
Chairman, President and CEO
32,000
0.144%
$1.55$49,580-65.16%
2020-06-10PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
Chairman, President and CEO
2,400
0.0216%
$4.09$9,816-36.76%
2019-01-15PurchaseOutlook Therapeutics, Inc.
OTLK
16,000
0.0177%
$0.68$10,880-66.82%
2018-01-04SaleOutlook Therapeutics, Inc.
OTLK
President & CEO
125,138
0.4793%
$1.16$145,160-23.53%
2018-01-03SaleOutlook Therapeutics, Inc.
OTLK
President & CEO
104,216
0.412%
$1.18$122,975-22.41%
2017-12-19SaleOutlook Therapeutics, Inc.
OTLK
President & CEO
167,216
0.6516%
$1.14$190,626-22.22%
2017-12-18SaleOutlook Therapeutics, Inc.
OTLK
President & CEO
41,046
0.1614%
$1.17$48,024-23.53%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.